4 Patents
- US126124622026Treatment and Inhibition of Inflammatory Lung Diseases in Patients Having Risk Alleles in the Genes Encoding IL33 and IL1RL1
Regeneron Pharmaceuticals, Inc.
0 cites - US122866772025Inhibition of HSD17B13 in the Treatment of Liver Disease in Patients Expressing the PNPLA3 I148M Variation
Regeneron Pharmaceuticals, Inc.
0 cites - US117084152023Treatment and Inhibition of Inflammatory Lung Diseases in Patients Having Risk Alleles in the Genes Encoding IL33 and IL1RL1
Regeneron Pharmaceuticals, Inc.
0 cites - US117027002023Inhibition of HSD17B13 in the Treatment of Liver Disease in Patients Expressing the PNPLA3 I148M Variation
Regeneron Pharmaceuticals, Inc.
0 cites